Shoreline Biosciences was a San Diego, California clinical-stage biotechnology company developing off-the-shelf, allogeneic cell therapies from induced pluripotent stem cells (iPSCs), principally iPSC-derived natural killer (iNK) cells and macrophages engineered for oncology indications. It raised roughly $140M, acquired Editas Medicine's iNK cell franchise and related gene-editing technologies in 2023, and signed collaborations with Kite Pharma (Gilead) and BeiGene with headline values above $4B. Therapeutics, not software, were the product: no developer program, API, SDK or machine-readable specification was ever published. As of this profiling pass the company's own domain, shorelinebio.com, no longer serves a website — it answers HTTP 404 with a Squarespace "Website Expired" holding page — and the company is tracked here only as a secondary-market entity.
Shoreline Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Cell Therapy, and Immunotherapy.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: shoreline-biosciences
name: Shoreline Biosciences
description: 'Shoreline Biosciences was a San Diego, California clinical-stage biotechnology company developing off-the-shelf,
allogeneic cell therapies from induced pluripotent stem cells (iPSCs), principally iPSC-derived natural killer (iNK) cells
and macrophages engineered for oncology indications. It raised roughly $140M, acquired Editas Medicine''s iNK cell franchise
and related gene-editing technologies in 2023, and signed collaborations with Kite Pharma (Gilead) and BeiGene with headline
values above $4B. Therapeutics, not software, were the product: no developer program, API, SDK or machine-readable specification
was ever published. As of this profiling pass the company''s own domain, shorelinebio.com, no longer serves a website —
it answers HTTP 404 with a Squarespace "Website Expired" holding page — and the company is tracked here only as a secondary-market
entity.'
url: https://raw.githubusercontent.com/api-evangelist/shoreline-biosciences/refs/heads/main/apis.yml
x-type: company
x-status: defunct
x-status-detail: Company wound down; shorelinebio.com is expired and answers HTTP 404 with a Squarespace "Website Expired"
holding page. Tracked here only as a secondary-market entity.
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
specificationVersion: '0.20'
created: '2026-08-27'
modified: '2026-09-15'
tags:
- Company
- Biotechnology
- Life Sciences
- Cell Therapy
- Immunotherapy
- Oncology
- Stem Cells
- Pharmaceuticals
- Defunct
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/shoreline-biosciences-domain-security.yml
x-enrichment:
date: '2026-08-27'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: defunct
detail: Shoreline Biosciences' own domain shorelinebio.com no longer serves a website — both the apex and www answer HTTP
404 with a Squarespace "Website Expired" holding page — so there is no homepage, developer area, docs host or resolvable
api./docs./developer. subdomain left to profile.
evidence:
- url: https://www.shorelinebio.com/
status: 404
- url: https://shorelinebio.com/
status: 404
- url: https://www.shorelinebio.com/.well-known/agent-card.json
status: 404
- url: https://www.shorelinebio.com/openapi.json
status: 404
- url: https://www.shorelinebio.com/llms.txt
status: 404
- url: https://forgeglobal.com/shoreline-biosciences_stock/
status: 403
checked: '2026-08-27'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →